培训课件_转移性结直肠癌治疗的新进展Mar.pptVIP

* New Developments in the Treatment of Colorectal Cancer * * * FOLFOX, 5-fluorouracil, leucovorin, and oxaliplatin; mFOLFOX, modified 5-fluorouracil, leucovorin, and oxaliplatin; sLV5FU2, simplified leucovorin plus bolus and infusional fluorouracil. * OS, overall survival; PFS, progression-free survival. * * * * ECOG, Eastern Cooperative Oncology Group; mCRC, metastatic colorectal cancer; PS, performance score; q3w, every 3 weeks. * * * Bev, bevacizumab; ITT, intention to treat; XELOX, capecitabine, oxaliplatin. * CR, complete response; FOLFIRI, leucovorin/fluorouracil/irino